title: Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C.
abstract: OBJECTIVE
  Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, being a putative steatogenic factor, may promote liver fibrosis progression in patients with chronic hepatitis C. This study aimed to verify the role of recipient MTHFR polymorphism in favouring graft fibrosis progression in patients with recurrent HCV after orthotopic liver transplantation (OLT).
  
  
  METHODS
  We studied 63 such patients, followed for >1 year. MTHFR allelic variants were determined by a polymerase chain reaction/restriction fragment length polymorphism method.
  
  
  RESULTS
  Recipients carrying the TT genotype had more frequently, 1-year post-OLT, homocysteine serum levels >23 micromol/L (P<0.05), serum triglycerides >180 mg/dL (P<0.02) and de novo diabetes mellitus (P<0.05) but not a higher frequency of graft steatosis. Time-to-event analysis in reaching an Ishak staging score >2 was performed by stratifying the recipients as follows: (a) patients with donor age < or =45 years, (b) patients with donor age >45 and C/(*) genotype, and (c) patients with donor age >45 years and TT genotype. A significant linear trend was observed, with increasing frequencies as follows: (a) 8/37, (b) 10/19 and (c) 6/7 (P=0.0005).
  
  
  CONCLUSIONS
  The MTHFR C677T polymorphism may play a role in influencing liver fibrosis progression in patients with recurrent hepatitis C, in conjunction with donor age, but not via steatosis promotion.
authors: Department of Pathology and Medicine Experimental and Clinical, Medical Liver Transplant Unit, University of Udine, Udine, Italy.
authors: Pierluigi
authors: P
authors: Toniutto
authors: Carlo
authors: C
authors: Fabris
authors: Edmondo
authors: E
authors: Falleti
authors: Annarosa
authors: A
authors: Cussigh
authors: Elisabetta
authors: E
authors: Fontanini
authors: Davide
authors: D
authors: Bitetto
authors: Ezio
authors: E
authors: Fornasiere
authors: Rosalba
authors: R
authors: Minisini
authors: Tullia
authors: T
authors: De Feo
authors: Francesca
authors: F
authors: Marangoni
authors: Mario
authors: M
authors: Pirisi
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D018450:Disease Progression; D005260:Female; D019698:Hepatitis C, Chronic / Q000601:surgery*; D006710:Homocysteine / Q000097:blood; D006801:Humans; D008103:Liver Cirrhosis / Q000209:etiology / Q000235:genetics*; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D008875:Middle Aged; D012150:Polymorphism, Restriction Fragment Length; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D012008:Recurrence
chemical_list: D006710:Homocysteine; D042965:Methylenetetrahydrofolate Reductase (NADPH2)